Babyscreen Polskasp. z o.o.
Other research and experimental development on natural sciences and engineering
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2022-01-10
Share capital
40 000,00 PLN
Registered address
ul. 27 Grudnia 5/5a, 61-737 Poznań, Poland
Website
babyscreen.plWebsite active
Financials
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Industry
Bank accounts
Registered as a VAT taxpayer on 2022-01-15. Active
No bank accounts reported to the VAT Taxpayer Register.
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Per Axel Svensson – Management Board Member
Simon Henry Pålsson – Management Board Member
Michał Krzysztof Zawiasa – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Body Screen Sweden Ab | 640 | $8,643.98 | 80% |
| 160 | $2,160.99 | 20% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Laboratorium Badawcze Sorbolabsp. z o.o. | $1,593,152.63 | sorbolab.pl | ||
| Centrum Alergologiisp. z o.o. | $812,503.07 | centrumalergologii.pl | ||
| Reumedikasp. z o.o. | $323,427.61 | reumedika.pl | ||
| Wielkopolskie Centrum Medycyny Podróżysp. z o.o. | $175,243.92 | medtrop.pl | ||
| Green Cenergysp. z o.o. | $47,243.84 | greencenergy.pl | ||
| EmpekoS.A. | $13,339.66 | empeko.pl | ||
| Biuro Studiów Inżynierskich Resolv3d Poznańsp. z o.o. | $3,223.34 | resolv3d.pl | ||
| Klause&StaschS.A. | $2,988.76 | klausestasch.kmpsa.net.pl | ||
| Optiliosp. z o.o. | $2,789.21 | optil.io | ||
| Empyriosp. z o.o. | $753.70 | empyrio.com |
Change history
| Date | Event | |
|---|---|---|
| 2022-09-19 | Name change (Bodyscreen Polska → Babyscreen Polska) | |
| 2022-06-23 | Share capital change (5,000.00 PLN → 40,000.00 PLN) | |
| 2022-06-23 | Name change (Trestol → Bodyscreen Polska) | |
| 2022-06-23 | PKD change (Removed: 45, 46, 47, 50, 70.22.Z; Added: 63, 71, 72.19.Z, 73, 74) | |
| 2022-01-10 | Entered in the register |
FAQ
The main business activity of Babyscreen Polska focuses on other research and experimental development on natural sciences and engineering.
The company was registered in the Polish National Court Register (KRS) on January 10, 2022.
The headquarters is located at: ul. 27 Grudnia 5, 61-737 Poznań.
The management board includes Michał Krzysztof Zawiasa (President of the Management Board).
The share capital of the company is PLN 40,000 (approx. $10,805).
The latest available financial statement covers the period from January 10, 2022 to December 31, 2022.
In 2022, the company generated total revenue of USD 0.
No, in 2022 the company was not profitable, reporting a net loss of USD 762.
The largest operating cost category falls under other operating costs. This category amounted to USD 762 in 2022, representing 100% of all operating expenses.
Last updated: 2026-08-17